Healthcare - Sector
NVAX is currently covered by 5 analysts with an average price target of $14.5. This is a potential upside of $7.03 (94.11%) from yesterday's end of day stock price of $7.47.
Novavax's activity chart (see below) currently has 243 price targets and 204 ratings on display. The stock rating distribution of NVAX is 60% BUY, 20% HOLD and 20% SELL.
Analysts' price targets on this stock were met 62.67% of the time, taking 169.75 days on average.
Highest price target for NVAX is $18, Lowest price target is $8, average price target is $14.5.
Most recent stock forecast was given by GEOFF MEACHAM from CITI on 15-Oct-2026. First documented stock forecast 19-Sep-2014.
Currently out of the existing stock ratings of NVAX, 3 are a BUY (60%), 1 are a HOLD (20%), 1 are a SELL (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 17-Jun-2025
$8
$0.53 (7.10%)
$6
1 months 6 days ago
(15-Oct-2026)
1/2 (50%)
$-4.82 (-37.60%)
33
Buy Since 28-Aug-2025
$16
$8.53 (114.19%)
$16
7 months ago
(21-Apr-2026)
2/4 (50%)
$7.51 (88.46%)
154
Buy Since 24-Oct-2025
$18
$10.53 (140.96%)
$18
10 months 8 days ago
(12-Jan-2026)
0/2 (0%)
$9.33 (107.61%)
Buy Since 23-Feb-2024
$16
$22
1 years 11 days ago
(10-Nov-2025)
13/39 (33.33%)
$8.89 (125.04%)
100
Hold Since 13-May-2024
$7
$8
1 years 17 days ago
(04-Nov-2025)
3/3 (100%)
$-0.51 (-6.79%)
59
What is NVAX (Novavax) average time for price targets to be met?
Which analyst most recently updated their price target on NVAX (Novavax)?
Which analyst has the most public recommendations on NVAX (Novavax)?
Which analyst is the currently most bullish on NVAX (Novavax)?
Which analyst is the currently most reserved on NVAX (Novavax)?